|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1994-7-1
|
|
pubmed:abstractText |
This study attempted to determine the efficacy of the combination of etoposide (VP-16), methyl-prednisolone, and cytarabine (Ara-C) with or without cisplatin in relapsing and refractory adult lymphoma patients.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1169-76
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8201379-Adolescent,
pubmed-meshheading:8201379-Adult,
pubmed-meshheading:8201379-Aged,
pubmed-meshheading:8201379-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8201379-Cisplatin,
pubmed-meshheading:8201379-Cytarabine,
pubmed-meshheading:8201379-Etoposide,
pubmed-meshheading:8201379-Female,
pubmed-meshheading:8201379-Follow-Up Studies,
pubmed-meshheading:8201379-Humans,
pubmed-meshheading:8201379-Lymphoma,
pubmed-meshheading:8201379-Male,
pubmed-meshheading:8201379-Methylprednisolone,
pubmed-meshheading:8201379-Middle Aged,
pubmed-meshheading:8201379-Prognosis,
pubmed-meshheading:8201379-Recurrence,
pubmed-meshheading:8201379-Remission Induction,
pubmed-meshheading:8201379-Survival Rate
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study.
|
|
pubmed:affiliation |
Section of Lymphoma, M.D. Anderson Cancer Center, Houston, TX.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
